Aurora Cannabis denies news of Medleaf Therapeutics acquisition
Aurora Cannabis denies news of Medleaf Therapeutics acquisition
Aurora Cannabis stock rises in premarket on narrower loss from the year-ago period
257.29MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
CA05156X8843
CUSIP
05156X108
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
March
IPO date
-
Updated At
-
PE Ratio
20.14
PEG Ratio
-
Book Value
10.09
Dividend Share
-
Dividend Yield
-
Earnings Share
0.22
Wall Street Target Price
32.07
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
343,292,992
Gross Profit TTM
187,607,008
EBITDA
30,659,000
Profit Margin
0.66%
Return On Assets TTM
0.62%
Return On Equity TTM
2.60%
Revenue Per Share TTM
6.261
Qtly Revenue Growth YOY
34.30%
Diluted Eps TTM
0.22
Qtly Earnings Growth YOY
-91.70%
Trailing PE
20.14
Forward PE
101
Price Sales TTM
0.7495
Price Book MRQ
0.5981
Enterprise Value Revenue
0
Enterprise Value EBITDA
5
29.32
3.42%26.16
2.15%131.80
1.93%157.80
0.50%55.00
0.31%152.00
0.00%18.00
0.00%16.72
-0.83%10.09
-0.64%15.01
-0.40%